s of its future results and revenues, including the expectation that Phase 2 of New BAC will yield annualized cost savings of $3 billion by mid-2015 and total New BAC savings of $8 billion; the company exceeding its previously announced 20 percent targeted Phase 1 cost savings by the end of 2012; the company's position for long-term growth; the company anticipates it will be in compliance with any